BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260514T054754
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:15586-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260514T054754
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:26362-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260514T054754
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:27976-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260514T054754
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:31061-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260514T054754
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:32521-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260514T054754
CREATED:20210302T161549Z
LAST-MODIFIED:20210316T171417Z
UID:15247-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260514T054754
CREATED:20210302T161549Z
LAST-MODIFIED:20210302T161549Z
UID:26350-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260514T054754
CREATED:20210302T161549Z
LAST-MODIFIED:20210302T161549Z
UID:27965-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260514T054754
CREATED:20210302T161549Z
LAST-MODIFIED:20210302T161549Z
UID:31048-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260514T054754
CREATED:20210302T161549Z
LAST-MODIFIED:20210302T161549Z
UID:32508-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260514T054754
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:15575-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260514T054754
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:26358-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260514T054754
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:27972-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260514T054754
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:31057-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260514T054754
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:32517-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210406T160000
DTEND;TZID=America/Vancouver:20210406T170000
DTSTAMP:20260514T054754
CREATED:20210326T232302Z
LAST-MODIFIED:20210405T042341Z
UID:15799-1617724800-1617728400@scienceinvancouver.com
SUMMARY:entrepreneurship@UBC’s Community Town Hall
DESCRIPTION:UBC is one of world’s top 40 research universities\, home to incredible research and innovation changing the world as we know it. entrepreneurship@UBC leverages this innovation through venture creation to make positive advancements and drive global change. That’s why we are thrilled to celebrate the launch of our Human Health Venture (H²V) Studio\, for UBC scientists and researchers looking to commercialize their transformative health innovations through venture creation! \nDetails \nJoin us April 6th to learn more about the launch of our new H²V Studio: find out who it’s for and how our entire ecosystem will benefit. Plus\, meet the newest ventures to join the Spring cohort of our Lab2Launch Venture Building Program and be the first to find out about our next BIG event happening in May you do not want to miss! \n  \n  \nDuring this event\, you will: \n\nHear from our Associate Director\, Lab2Launch\, Sean Lumb\, on the launch of our new Human Health Venture Studio! Find out who it’s for and how you can get involved.\n\n\nMeet the latest cohort of ventures in our Lab2Launch program and be the first to know about our next big event you don’t want to miss!\n\n\nFind out what’s coming down the pipeline for ventures and share your recent news/accomplishments with the community. Are you hiring?\n\n\n\n\nConnect with like-minded entrepreneurs and innovators.\n\n\n\n  \n  \nFormat \nThis event will begin with the latest updates and information coming from the entrepreneurship@UBC community\, followed by an introduction to our newest Venture Studio! \n\nWelcome\nAnnouncements\nMeet the newest cohort of Lab2Launch ventures\nLearn about the Human Health Venture (H²V) Studio\nOpen Mic (Share YOUR latest news!)\n\n  \n  \nWho should attend \nThis event is for entrepreneurship@UBC’s community of ventures from Phases 1-4/HATCH\, Entrepreneurs in Residence (EiRs)\, Mentors\, and the UBC community at large. \nAnyone interested in the Human Health Venture Studio\, our upcoming programming and venture ecosystem is encouraged to attend. \n  \n  \nSession information \nZoom information will be available via your registration confirmation email. As well\, it will be on the online event page. Attendees will also be sent the Zoom link and password to their registered email in advance of the session. \n  \nAbout entrepreneurship@UBC \nentrepreneurship@UBC propels UBC innovations out into the world through venture creation\, providing UBC students\, researchers\, faculty members\, alumni and staff with the resources\, networks\, and funding they need to succeed. \nAs one of the world’s top 40 research universities with 80\,000 students\, faculty and staff and over $650M annual research funding\, UBC has long been a catalyst for innovation. Part of the Innovation UBC network\, entrepreneurship@UBC supports UBC ventures and entrepreneurs to generate social and economic impacts in B.C. and around the world. To date\, entrepreneurship@UBC has worked with over 484 ventures who have raised more than $1.38 billion in financing\, generated more than $104 million in revenue and hired more than 919 employees\, stimulating the economic and social landscape of B.C. while building anchor companies that have a global impact. \nVisit our website entrepreneurship.ubc.ca to learn more \n  \nAbout the Human Health Venture Studio \nentrepreneurship@UBC’s Human Health Venture (H²V) Studio supports UBC entrepreneurs who are innovating in health industries through specialized programming\, industry and academic mentorship\, community engagement and network development to help them commercialize transformative human health innovations through venture creation.
URL:https://scienceinvancouver.com/event/entrepreneurshipubcs-community-town-hall/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210406T160000
DTEND;TZID=America/Vancouver:20210406T170000
DTSTAMP:20260514T054754
CREATED:20210326T232302Z
LAST-MODIFIED:20210326T232302Z
UID:26368-1617724800-1617728400@scienceinvancouver.com
SUMMARY:entrepreneurship@UBC’s Community Town Hall
DESCRIPTION:UBC is one of world’s top 40 research universities\, home to incredible research and innovation changing the world as we know it. entrepreneurship@UBC leverages this innovation through venture creation to make positive advancements and drive global change. That’s why we are thrilled to celebrate the launch of our Human Health Venture (H²V) Studio\, for UBC scientists and researchers looking to commercialize their transformative health innovations through venture creation! \nDetails \nJoin us April 6th to learn more about the launch of our new H²V Studio: find out who it’s for and how our entire ecosystem will benefit. Plus\, meet the newest ventures to join the Spring cohort of our Lab2Launch Venture Building Program and be the first to find out about our next BIG event happening in May you do not want to miss! \n  \n  \nDuring this event\, you will: \n\nHear from our Associate Director\, Lab2Launch\, Sean Lumb\, on the launch of our new Human Health Venture Studio! Find out who it’s for and how you can get involved.\n\n\nMeet the latest cohort of ventures in our Lab2Launch program and be the first to know about our next big event you don’t want to miss!\n\n\nFind out what’s coming down the pipeline for ventures and share your recent news/accomplishments with the community. Are you hiring?\n\n\n\n\nConnect with like-minded entrepreneurs and innovators.\n\n\n\n  \n  \nFormat \nThis event will begin with the latest updates and information coming from the entrepreneurship@UBC community\, followed by an introduction to our newest Venture Studio! \n\nWelcome\nAnnouncements\nMeet the newest cohort of Lab2Launch ventures\nLearn about the Human Health Venture (H²V) Studio\nOpen Mic (Share YOUR latest news!)\n\n  \n  \nWho should attend \nThis event is for entrepreneurship@UBC’s community of ventures from Phases 1-4/HATCH\, Entrepreneurs in Residence (EiRs)\, Mentors\, and the UBC community at large. \nAnyone interested in the Human Health Venture Studio\, our upcoming programming and venture ecosystem is encouraged to attend. \n  \n  \nSession information \nZoom information will be available via your registration confirmation email. As well\, it will be on the online event page. Attendees will also be sent the Zoom link and password to their registered email in advance of the session. \n  \nAbout entrepreneurship@UBC \nentrepreneurship@UBC propels UBC innovations out into the world through venture creation\, providing UBC students\, researchers\, faculty members\, alumni and staff with the resources\, networks\, and funding they need to succeed. \nAs one of the world’s top 40 research universities with 80\,000 students\, faculty and staff and over $650M annual research funding\, UBC has long been a catalyst for innovation. Part of the Innovation UBC network\, entrepreneurship@UBC supports UBC ventures and entrepreneurs to generate social and economic impacts in B.C. and around the world. To date\, entrepreneurship@UBC has worked with over 484 ventures who have raised more than $1.38 billion in financing\, generated more than $104 million in revenue and hired more than 919 employees\, stimulating the economic and social landscape of B.C. while building anchor companies that have a global impact. \nVisit our website entrepreneurship.ubc.ca to learn more \n  \nAbout the Human Health Venture Studio \nentrepreneurship@UBC’s Human Health Venture (H²V) Studio supports UBC entrepreneurs who are innovating in health industries through specialized programming\, industry and academic mentorship\, community engagement and network development to help them commercialize transformative human health innovations through venture creation.
URL:https://scienceinvancouver.com/event/entrepreneurshipubcs-community-town-hall-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210406T160000
DTEND;TZID=America/Vancouver:20210406T170000
DTSTAMP:20260514T054754
CREATED:20210326T232302Z
LAST-MODIFIED:20210326T232302Z
UID:27983-1617724800-1617728400@scienceinvancouver.com
SUMMARY:entrepreneurship@UBC’s Community Town Hall
DESCRIPTION:UBC is one of world’s top 40 research universities\, home to incredible research and innovation changing the world as we know it. entrepreneurship@UBC leverages this innovation through venture creation to make positive advancements and drive global change. That’s why we are thrilled to celebrate the launch of our Human Health Venture (H²V) Studio\, for UBC scientists and researchers looking to commercialize their transformative health innovations through venture creation! \nDetails \nJoin us April 6th to learn more about the launch of our new H²V Studio: find out who it’s for and how our entire ecosystem will benefit. Plus\, meet the newest ventures to join the Spring cohort of our Lab2Launch Venture Building Program and be the first to find out about our next BIG event happening in May you do not want to miss! \n  \n  \nDuring this event\, you will: \n\nHear from our Associate Director\, Lab2Launch\, Sean Lumb\, on the launch of our new Human Health Venture Studio! Find out who it’s for and how you can get involved.\n\n\nMeet the latest cohort of ventures in our Lab2Launch program and be the first to know about our next big event you don’t want to miss!\n\n\nFind out what’s coming down the pipeline for ventures and share your recent news/accomplishments with the community. Are you hiring?\n\n\n\n\nConnect with like-minded entrepreneurs and innovators.\n\n\n\n  \n  \nFormat \nThis event will begin with the latest updates and information coming from the entrepreneurship@UBC community\, followed by an introduction to our newest Venture Studio! \n\nWelcome\nAnnouncements\nMeet the newest cohort of Lab2Launch ventures\nLearn about the Human Health Venture (H²V) Studio\nOpen Mic (Share YOUR latest news!)\n\n  \n  \nWho should attend \nThis event is for entrepreneurship@UBC’s community of ventures from Phases 1-4/HATCH\, Entrepreneurs in Residence (EiRs)\, Mentors\, and the UBC community at large. \nAnyone interested in the Human Health Venture Studio\, our upcoming programming and venture ecosystem is encouraged to attend. \n  \n  \nSession information \nZoom information will be available via your registration confirmation email. As well\, it will be on the online event page. Attendees will also be sent the Zoom link and password to their registered email in advance of the session. \n  \nAbout entrepreneurship@UBC \nentrepreneurship@UBC propels UBC innovations out into the world through venture creation\, providing UBC students\, researchers\, faculty members\, alumni and staff with the resources\, networks\, and funding they need to succeed. \nAs one of the world’s top 40 research universities with 80\,000 students\, faculty and staff and over $650M annual research funding\, UBC has long been a catalyst for innovation. Part of the Innovation UBC network\, entrepreneurship@UBC supports UBC ventures and entrepreneurs to generate social and economic impacts in B.C. and around the world. To date\, entrepreneurship@UBC has worked with over 484 ventures who have raised more than $1.38 billion in financing\, generated more than $104 million in revenue and hired more than 919 employees\, stimulating the economic and social landscape of B.C. while building anchor companies that have a global impact. \nVisit our website entrepreneurship.ubc.ca to learn more \n  \nAbout the Human Health Venture Studio \nentrepreneurship@UBC’s Human Health Venture (H²V) Studio supports UBC entrepreneurs who are innovating in health industries through specialized programming\, industry and academic mentorship\, community engagement and network development to help them commercialize transformative human health innovations through venture creation.
URL:https://scienceinvancouver.com/event/entrepreneurshipubcs-community-town-hall-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210406T160000
DTEND;TZID=America/Vancouver:20210406T170000
DTSTAMP:20260514T054754
CREATED:20210326T232302Z
LAST-MODIFIED:20210326T232302Z
UID:31066-1617724800-1617728400@scienceinvancouver.com
SUMMARY:entrepreneurship@UBC’s Community Town Hall
DESCRIPTION:UBC is one of world’s top 40 research universities\, home to incredible research and innovation changing the world as we know it. entrepreneurship@UBC leverages this innovation through venture creation to make positive advancements and drive global change. That’s why we are thrilled to celebrate the launch of our Human Health Venture (H²V) Studio\, for UBC scientists and researchers looking to commercialize their transformative health innovations through venture creation! \nDetails \nJoin us April 6th to learn more about the launch of our new H²V Studio: find out who it’s for and how our entire ecosystem will benefit. Plus\, meet the newest ventures to join the Spring cohort of our Lab2Launch Venture Building Program and be the first to find out about our next BIG event happening in May you do not want to miss! \n  \n  \nDuring this event\, you will: \n\nHear from our Associate Director\, Lab2Launch\, Sean Lumb\, on the launch of our new Human Health Venture Studio! Find out who it’s for and how you can get involved.\n\n\nMeet the latest cohort of ventures in our Lab2Launch program and be the first to know about our next big event you don’t want to miss!\n\n\nFind out what’s coming down the pipeline for ventures and share your recent news/accomplishments with the community. Are you hiring?\n\n\n\n\nConnect with like-minded entrepreneurs and innovators.\n\n\n\n  \n  \nFormat \nThis event will begin with the latest updates and information coming from the entrepreneurship@UBC community\, followed by an introduction to our newest Venture Studio! \n\nWelcome\nAnnouncements\nMeet the newest cohort of Lab2Launch ventures\nLearn about the Human Health Venture (H²V) Studio\nOpen Mic (Share YOUR latest news!)\n\n  \n  \nWho should attend \nThis event is for entrepreneurship@UBC’s community of ventures from Phases 1-4/HATCH\, Entrepreneurs in Residence (EiRs)\, Mentors\, and the UBC community at large. \nAnyone interested in the Human Health Venture Studio\, our upcoming programming and venture ecosystem is encouraged to attend. \n  \n  \nSession information \nZoom information will be available via your registration confirmation email. As well\, it will be on the online event page. Attendees will also be sent the Zoom link and password to their registered email in advance of the session. \n  \nAbout entrepreneurship@UBC \nentrepreneurship@UBC propels UBC innovations out into the world through venture creation\, providing UBC students\, researchers\, faculty members\, alumni and staff with the resources\, networks\, and funding they need to succeed. \nAs one of the world’s top 40 research universities with 80\,000 students\, faculty and staff and over $650M annual research funding\, UBC has long been a catalyst for innovation. Part of the Innovation UBC network\, entrepreneurship@UBC supports UBC ventures and entrepreneurs to generate social and economic impacts in B.C. and around the world. To date\, entrepreneurship@UBC has worked with over 484 ventures who have raised more than $1.38 billion in financing\, generated more than $104 million in revenue and hired more than 919 employees\, stimulating the economic and social landscape of B.C. while building anchor companies that have a global impact. \nVisit our website entrepreneurship.ubc.ca to learn more \n  \nAbout the Human Health Venture Studio \nentrepreneurship@UBC’s Human Health Venture (H²V) Studio supports UBC entrepreneurs who are innovating in health industries through specialized programming\, industry and academic mentorship\, community engagement and network development to help them commercialize transformative human health innovations through venture creation.
URL:https://scienceinvancouver.com/event/entrepreneurshipubcs-community-town-hall-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210406T160000
DTEND;TZID=America/Vancouver:20210406T170000
DTSTAMP:20260514T054754
CREATED:20210326T232302Z
LAST-MODIFIED:20210326T232302Z
UID:32526-1617724800-1617728400@scienceinvancouver.com
SUMMARY:entrepreneurship@UBC’s Community Town Hall
DESCRIPTION:UBC is one of world’s top 40 research universities\, home to incredible research and innovation changing the world as we know it. entrepreneurship@UBC leverages this innovation through venture creation to make positive advancements and drive global change. That’s why we are thrilled to celebrate the launch of our Human Health Venture (H²V) Studio\, for UBC scientists and researchers looking to commercialize their transformative health innovations through venture creation! \nDetails \nJoin us April 6th to learn more about the launch of our new H²V Studio: find out who it’s for and how our entire ecosystem will benefit. Plus\, meet the newest ventures to join the Spring cohort of our Lab2Launch Venture Building Program and be the first to find out about our next BIG event happening in May you do not want to miss! \n  \n  \nDuring this event\, you will: \n\nHear from our Associate Director\, Lab2Launch\, Sean Lumb\, on the launch of our new Human Health Venture Studio! Find out who it’s for and how you can get involved.\n\n\nMeet the latest cohort of ventures in our Lab2Launch program and be the first to know about our next big event you don’t want to miss!\n\n\nFind out what’s coming down the pipeline for ventures and share your recent news/accomplishments with the community. Are you hiring?\n\n\n\n\nConnect with like-minded entrepreneurs and innovators.\n\n\n\n  \n  \nFormat \nThis event will begin with the latest updates and information coming from the entrepreneurship@UBC community\, followed by an introduction to our newest Venture Studio! \n\nWelcome\nAnnouncements\nMeet the newest cohort of Lab2Launch ventures\nLearn about the Human Health Venture (H²V) Studio\nOpen Mic (Share YOUR latest news!)\n\n  \n  \nWho should attend \nThis event is for entrepreneurship@UBC’s community of ventures from Phases 1-4/HATCH\, Entrepreneurs in Residence (EiRs)\, Mentors\, and the UBC community at large. \nAnyone interested in the Human Health Venture Studio\, our upcoming programming and venture ecosystem is encouraged to attend. \n  \n  \nSession information \nZoom information will be available via your registration confirmation email. As well\, it will be on the online event page. Attendees will also be sent the Zoom link and password to their registered email in advance of the session. \n  \nAbout entrepreneurship@UBC \nentrepreneurship@UBC propels UBC innovations out into the world through venture creation\, providing UBC students\, researchers\, faculty members\, alumni and staff with the resources\, networks\, and funding they need to succeed. \nAs one of the world’s top 40 research universities with 80\,000 students\, faculty and staff and over $650M annual research funding\, UBC has long been a catalyst for innovation. Part of the Innovation UBC network\, entrepreneurship@UBC supports UBC ventures and entrepreneurs to generate social and economic impacts in B.C. and around the world. To date\, entrepreneurship@UBC has worked with over 484 ventures who have raised more than $1.38 billion in financing\, generated more than $104 million in revenue and hired more than 919 employees\, stimulating the economic and social landscape of B.C. while building anchor companies that have a global impact. \nVisit our website entrepreneurship.ubc.ca to learn more \n  \nAbout the Human Health Venture Studio \nentrepreneurship@UBC’s Human Health Venture (H²V) Studio supports UBC entrepreneurs who are innovating in health industries through specialized programming\, industry and academic mentorship\, community engagement and network development to help them commercialize transformative human health innovations through venture creation.
URL:https://scienceinvancouver.com/event/entrepreneurshipubcs-community-town-hall-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210407T120000
DTEND;TZID=America/Vancouver:20210407T130000
DTSTAMP:20260514T054754
CREATED:20210315T192909Z
LAST-MODIFIED:20210403T000001Z
UID:15584-1617796800-1617800400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Chonnettia Jones
DESCRIPTION:Research in a Pandemic: How MSFHR is learning from and adapting to COVID-19\nDr. Chonnettia Jones always had a curious mind. Growing up\, the natural world of plants and animals and their evolution enchanted her. That early curiosity led her to pursue research in developmental biology\, and the eventual realization that science creates knowledge that improves human health. \nAs VP Research at MSFHR\, she has seen first hand how the emergency response to COVID-19 has significantly impacted health researchers in British Columbia. She is helping MSFHR lead the way in supporting the province’s health research system during (and after) COVID-19\, and what it will take for a responsive and responsible funder to continue providing researchers the tools\, resources and infrastructure they need to do what they do best: develop the knowledge we need to stay healthy and save lives. \nDuring her presentation\, Dr. Jones will shine the light on MSFHR’s learnings during the pandemic as BC’s health research funding agency and its response\, her own insights from her extensive career in research\, health policy\, and funding\, and the systemic inequities throughout the research enterprise that were exacerbated during the pandemic and need to be urgently addressed to ensure all researchers can flourish in the future.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-chonnettia-jones-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210407T120000
DTEND;TZID=America/Vancouver:20210407T130000
DTSTAMP:20260514T054754
CREATED:20210315T192909Z
LAST-MODIFIED:20210315T192909Z
UID:26361-1617796800-1617800400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Chonnettia Jones
DESCRIPTION:Research in a Pandemic: How MSFHR is learning from and adapting to COVID-19\nDr. Chonnettia Jones always had a curious mind. Growing up\, the natural world of plants and animals and their evolution enchanted her. That early curiosity led her to pursue research in developmental biology\, and the eventual realization that science creates knowledge that improves human health. \nAs VP Research at MSFHR\, she has seen first hand how the emergency response to COVID-19 has significantly impacted health researchers in British Columbia. She is helping MSFHR lead the way in supporting the province’s health research system during (and after) COVID-19\, and what it will take for a responsive and responsible funder to continue providing researchers the tools\, resources and infrastructure they need to do what they do best: develop the knowledge we need to stay healthy and save lives. \nDuring her presentation\, Dr. Jones will shine the light on MSFHR’s learnings during the pandemic as BC’s health research funding agency and its response\, her own insights from her extensive career in research\, health policy\, and funding\, and the systemic inequities throughout the research enterprise that were exacerbated during the pandemic and need to be urgently addressed to ensure all researchers can flourish in the future.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-chonnettia-jones-2-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210407T120000
DTEND;TZID=America/Vancouver:20210407T130000
DTSTAMP:20260514T054754
CREATED:20210315T192909Z
LAST-MODIFIED:20210315T192909Z
UID:27975-1617796800-1617800400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Chonnettia Jones
DESCRIPTION:Research in a Pandemic: How MSFHR is learning from and adapting to COVID-19\nDr. Chonnettia Jones always had a curious mind. Growing up\, the natural world of plants and animals and their evolution enchanted her. That early curiosity led her to pursue research in developmental biology\, and the eventual realization that science creates knowledge that improves human health. \nAs VP Research at MSFHR\, she has seen first hand how the emergency response to COVID-19 has significantly impacted health researchers in British Columbia. She is helping MSFHR lead the way in supporting the province’s health research system during (and after) COVID-19\, and what it will take for a responsive and responsible funder to continue providing researchers the tools\, resources and infrastructure they need to do what they do best: develop the knowledge we need to stay healthy and save lives. \nDuring her presentation\, Dr. Jones will shine the light on MSFHR’s learnings during the pandemic as BC’s health research funding agency and its response\, her own insights from her extensive career in research\, health policy\, and funding\, and the systemic inequities throughout the research enterprise that were exacerbated during the pandemic and need to be urgently addressed to ensure all researchers can flourish in the future.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-chonnettia-jones-2-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210407T120000
DTEND;TZID=America/Vancouver:20210407T130000
DTSTAMP:20260514T054754
CREATED:20210315T192909Z
LAST-MODIFIED:20210315T192909Z
UID:31060-1617796800-1617800400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Chonnettia Jones
DESCRIPTION:Research in a Pandemic: How MSFHR is learning from and adapting to COVID-19\nDr. Chonnettia Jones always had a curious mind. Growing up\, the natural world of plants and animals and their evolution enchanted her. That early curiosity led her to pursue research in developmental biology\, and the eventual realization that science creates knowledge that improves human health. \nAs VP Research at MSFHR\, she has seen first hand how the emergency response to COVID-19 has significantly impacted health researchers in British Columbia. She is helping MSFHR lead the way in supporting the province’s health research system during (and after) COVID-19\, and what it will take for a responsive and responsible funder to continue providing researchers the tools\, resources and infrastructure they need to do what they do best: develop the knowledge we need to stay healthy and save lives. \nDuring her presentation\, Dr. Jones will shine the light on MSFHR’s learnings during the pandemic as BC’s health research funding agency and its response\, her own insights from her extensive career in research\, health policy\, and funding\, and the systemic inequities throughout the research enterprise that were exacerbated during the pandemic and need to be urgently addressed to ensure all researchers can flourish in the future.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-chonnettia-jones-2-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210407T120000
DTEND;TZID=America/Vancouver:20210407T130000
DTSTAMP:20260514T054754
CREATED:20210315T192909Z
LAST-MODIFIED:20210315T192909Z
UID:32520-1617796800-1617800400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Chonnettia Jones
DESCRIPTION:Research in a Pandemic: How MSFHR is learning from and adapting to COVID-19\nDr. Chonnettia Jones always had a curious mind. Growing up\, the natural world of plants and animals and their evolution enchanted her. That early curiosity led her to pursue research in developmental biology\, and the eventual realization that science creates knowledge that improves human health. \nAs VP Research at MSFHR\, she has seen first hand how the emergency response to COVID-19 has significantly impacted health researchers in British Columbia. She is helping MSFHR lead the way in supporting the province’s health research system during (and after) COVID-19\, and what it will take for a responsive and responsible funder to continue providing researchers the tools\, resources and infrastructure they need to do what they do best: develop the knowledge we need to stay healthy and save lives. \nDuring her presentation\, Dr. Jones will shine the light on MSFHR’s learnings during the pandemic as BC’s health research funding agency and its response\, her own insights from her extensive career in research\, health policy\, and funding\, and the systemic inequities throughout the research enterprise that were exacerbated during the pandemic and need to be urgently addressed to ensure all researchers can flourish in the future.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-chonnettia-jones-2-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260514T054754
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:15849-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260514T054754
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:26371-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260514T054754
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:27986-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260514T054754
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:31069-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260514T054754
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:32529-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR